Osmolex ER Interactions
There are 131 drugs known to interact with Osmolex ER (amantadine), along with 7 disease interactions. Of the total drug interactions, 9 are major, 108 are moderate, and 14 are minor.
- View all 131 medications that may interact with Osmolex ER
- View Osmolex ER disease interactions (7)
Most frequently checked interactions
View interaction reports for Osmolex ER (amantadine) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- alpha-lipoic acid
- alprazolam
- atorvastatin
- benztropine
- carbidopa / levodopa
- cetirizine
- Cialis (tadalafil)
- citalopram
- clobetasol topical
- diphenhydramine
- Duopa (carbidopa / levodopa)
- entacapone
- escitalopram
- Flonase (fluticasone nasal)
- folic acid
- gabapentin
- hydrochlorothiazide
- hydroxyzine
- lamotrigine
- levothyroxine
- lorazepam
- melatonin
- midodrine
- omeprazole
- Rytary (carbidopa / levodopa)
- sertraline
- topiramate
- tramadol
- Vitamin D3 (cholecalciferol)
Osmolex ER disease interactions
There are 7 disease interactions with Osmolex ER (amantadine) which include:
- psychoses/depression
- renal dysfunction
- seizure disorders
- CHF/edema
- hypotension
- hypotension
- psychosis
More about Osmolex ER (amantadine)
- Osmolex ER consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.